The climate of Tianyue Island in late spring is very comfortable.

The sky is clear, and occasionally a sea breeze blows through, which makes people feel refreshed.

During the construction of Tianyue Island, the construction unit followed Chen Xiao's original design and ensured the integrity of the island's plants to the greatest extent. The reed marshes and mangroves added a touch of greenery to the island.

Because there are plants, animals will also be attracted.

It turns out that the habitats of birds, turtles and other creatures on the island have not been destroyed.

If someone uses a drone or helicopter to get a bird's eye view, then this is definitely an island park with excellent scenery.

Among the lush greenery are Changtian Technology's Severe Pulmonary Disease Treatment Center and Changtian Technology's newly built Natural Science Research Institute.

In the conference room of the critical care center, Chen Xiao organized the senior management of the treatment center to come to the meeting.

Qu Ping and others sat opposite Chen Xiao.

Senior executives such as Shurou and Huang Ling have heard about Bristol-Myers Squibb's relevant requirements and the pressure from relevant departments on Changtian Technology.

Just now, everyone was still talking about it.

I feel that as a private company, Changtian Technology’s most important thing is to be responsible for its own company, its employees, its users, and finally, society and the country.

The result of this discussion is not that the employees of Changtian Technology are selfish, but that the size of a private company is too small and cannot bear such a large responsibility.

People like Shu Rou and Huang Ling definitely cannot make decisions for their boss, but their discussion also represents the thoughts of some employees of the critical care center to a certain extent.

Many employees discussed in private and said: "It is impossible to let Changtian Technology, a private company, be responsible for the health of the entire Xia Kingdom people, right?"

"Changtian Technology does not have that much energy, nor does it have that much responsibility and responsibility."

Everyone in the conference room fell silent.

In fact, everyone knows that the boss Chen Xiao is under a lot of pressure.

The following complaints are complaints, but the actual situation faced by the company is another matter.

In the final analysis, Changtian Technology is a private company of Xia State.

We have a lot of cooperation with many departments of Xia State and related academies of science.

Everyone doesn’t know what decision Chen Xiao will make in the end.

At this time, Chen Xiao laughed and said: "Today we will have a short meeting. The theme of the meeting is to discuss how to deal with Bristol-Myers Squibb's initiative to cooperate with us."

Chen Xiao's laughter made the atmosphere in the conference room more relaxed.

Then Chen Xiao said to Qu Ping: "Qu Ping, please give me a list of your overseas patients."

Qu Ping immediately arranged for an assistant to print the list.

At this time, Chen Xiao said: "I think everyone should know what happened during this period."

"I also know that everyone has some different ideas in their minds, and they even feel a little aggrieved."

"Everyone is worried about why the medical achievements that Changtian Technology's life science and medical laboratories have worked so hard to develop are so easily given to foreign pharmaceutical companies?"

Chen Xiao never talks empty words during meetings.

Therefore, his opening remarks directly pointed out some of the thoughts of the employees below.

As soon as this was said, there was a lot of discussion.

"That's right, Mr. Chen, we absolutely cannot agree to cooperate with Bristol-Myers Squibb!"

“Although Bristol-Myers Squibb seems to be generous and is willing to hand over the agent for targeted therapy to us, it is just asking the agent to give us the agent instead of giving us the corresponding technology.”

"Furthermore, the costs associated with targeted therapy are already very expensive. Even if we get it, the patients we face will still be wealthy patients from Xia State, and it will not benefit the general public."

"This kind of deal is very detrimental to us."

Everyone in the conference room was chattering away, trying to express some of their opinions.

The more we talked about it, the more heated the atmosphere became. Some of the younger middle-level managers even felt indignant and aggrieved by Bristol-Myers Squibb's approach.

Chen Xiao just smiled. When he came to the middle and high-level people to talk, he didn't say a word from beginning to end.

After a long time, Chen Xiao pressed his hand and signaled everyone to quiet down.

By this time, Qu Ping's assistant had already printed out a list of more than 10,000 people.

The list of more than 10,000 people is just a long list of names, ages and some symptoms, so the list is very thick.

The assistant was worried that Qu Ping wanted to access the specific information of someone on the list, so he brought the laptop over.

Every patient who queues up for treatment has specific information. In addition to their name, age and symptoms, there is also their occupation, background, family situation, etc.

Therefore, these materials must never be printed out and can only be viewed at any time through a laptop computer connected to the treatment center's system.

Qu Ping got the list and sent it to Chen Xiao.

Only then did Chen Xiao say: "I know what everyone is thinking."

"I always feel that Shiguibao Company is putting pressure on relevant departments and the Xiaguo Academy of Sciences, and then letting these departments and the Xiaguo Academy of Sciences put pressure on Changtian Technology. This approach is unethical."

"But what I'm saying is, this is business."

"Everyone here is related to the company's life sciences and medical laboratories, or is a medical staff in the critical care center."

"In addition to our identity as researchers, we also have another identity as medical staff."

“What are the responsibilities of health care workers?”

Chen Xiao looked at everyone with a smile.

This question is actually very simple, even people outside the industry can answer it.

"The duty of medical staff is to save lives and heal the wounded."

Chen Xiao said with certainty: "We use combined colony therapy to treat patients and bring these severe patients back from the door of death."

"Similarly, major hospitals across the country use drugs such as Baludin and Cetaxel to treat hepatitis B patients or leukemia patients. The purpose is to save lives and heal the wounded. From this perspective, whether it is Changtian Technology's critical treatment center or Xia Guo's other

There is no essential difference between a hospital or even Bristol-Myers Squibb."

"Although Changtian Technology is a private company, we have the obligation and responsibility to make our own contribution to the health of the Chinese people."

"Xia has at least 100 million hepatitis B patients, and more and more teenagers are suffering from leukemia."

"There are some drugs that are life-saving for them, just like combined bacteria are life-saving drugs for some patients with severe lung diseases."

Chen Xiao glanced at the crowd and said: "I now hope that life sciences and medical laboratories can develop and expand in the future and overcome more medical research problems."

"I hope there will be drugs with better efficacy than Baludin and Cetaxel, and they will be born in our laboratory."

Chen Xiao's words made many middle- and high-level people at the scene lower their heads and dare not speak.

People occupy different positions and view problems from different heights.

Many young people in the middle class even clenched their fists and felt a surge of energy in their hearts.

They felt very frustrated.

Why is Changtian Technology under such coercion today?

It's because the scientific research capabilities of Xia's medical community are worse than those of the United States.

This is because Xia Guo’s medical industry still has no way to develop and produce many deadly drugs on its own, and can only rely on large pharmaceutical companies in the United States.

Begging from others will eventually lead to being controlled by others.

This is an eternal truth.

Everyone looked at Chen Xiao and felt very uncomfortable.

They all thought that the boss must have compromised with Bristol-Myers Squibb by saying so many things.

However, after what Chen Xiao said just now, the middle and senior management of Changtian Science and Technology Critical Care Center in Chengdu have already expressed their understanding.

Even if the boss finally decides to compromise with Bristol-Myers Squibb, everyone will be able to accept it.

Chen Xiao added: "But as a responsible company, we are willing to make our own contribution to the health of the Chinese people. This does not mean that Changtian Technology's life science and medical laboratories and planting information center are fat on the chopping board.

, to be slaughtered by others.”

Chen Xiao now changed the subject again, which made the people in the conference room suddenly raise their heads and look at Chen Xiao.

Chen Xiao smiled and said: "Everyone knows that Bristol-Myers Squibb used unfair means to coerce Changtian Technology."

"This approach is disgraceful."

"Since the other party is unwilling to negotiate with us legitimately and instead uses these petty tricks, Changtian Technology does not mind using some unfair means to fight back."

Chen Xiao shook the list in his hand and said: "According to the accurate figures in the background, there are currently 15,783 overseas patients who have paid deposits or paid in full and hope to be treated in our intensive care center."

"There are 8,627 patients in the United States."

Chen Xiao said: "Everyone knows that our critical care center adopts a dual-track charging system."

"For domestic patients, we will consider their financial conditions, so the fees must be within their affordability. Even if their family conditions are relatively poor, as long as they are indeed seriously ill, they can apply to our Tianyue Island for treatment.

.”

"But for overseas patients, the treatment fees we charge are more than ten times that of domestic patients. Part of the extra money is used to subsidize domestic patients, and the other part is directly deposited into the relevant funds established by us.
To be continued...